7 Reasons To Choose CLIA Kits For High-Sensitivity Immunoassays
By opting for CLIA kits, you’re not just choosing a tool—you’re choosing a solution that can enhance the efficiency and quality of your work.
July 9, 2025
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news including new biotech developments, pharmaceuticals and more.
Top 6 Trends Shaping the Future of CDMO Services
The global CDMO services market has expanded rapidly, projected to reach roughly $258 billion by 2028, reflecting this outsized demand.
July 8, 2025
Precisio Biotix Therapeutics, Inc. Announces Dosing of a 1st Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
The FDA approved this treatment under a compassionate.
July 3, 2025
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities
Through this partnership, Orphalan will donate a supply of Cuvrior® to MAP International, a global humanitarian health organization with over 70 years of experience distributing critical medicines to communities in need.
June 27, 2025
Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US
This purchase order is to service US hospitals through BioPorto’s distribution relationship with Roche Diagnostics.
June 27, 2025
ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
ENFLONSIA is the first and only RSV preventive option for administration to infants using the same dose regardless of weight. Ordering will begin in July, with shipments delivered before the start of the 2025-2026 RSV season
June 26, 2025